MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 82 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $69,000 | +25.5% | 27,000 | 0.0% | 0.00% | – |
Q1 2020 | $55,000 | -5.2% | 27,000 | 0.0% | 0.00% | – |
Q4 2019 | $58,000 | +38.1% | 27,000 | 0.0% | 0.00% | – |
Q3 2019 | $42,000 | -62.5% | 27,000 | 0.0% | 0.00% | -100.0% |
Q2 2019 | $112,000 | -0.9% | 27,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $113,000 | +130.6% | 27,000 | +58.8% | 0.00% | – |
Q4 2018 | $49,000 | – | 17,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |